Identification |
Name: | L-Tyrosine, 3-hydroxy-a-methyl- |
Synonyms: | Alanine,3-(3,4-dihydroxyphenyl)-2-methyl-, L- (8CI);(-)-Methyldopa;(S)-(-)-a-Methyldopa;2-Methyl-3-(3,4-dihydroxyphenyl)alanine;Aldometil;Alphamethyldopa;Baypresol;Dopatec;Equibar;L-(-)-a-Methyl-b-(3,4-dihydroxyphenyl)alanine;L-3,4-Dihydroxy-a-methylphenylalanine;Levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine;Medomet;Medopa;Methoplain;Methyldopa;NSC 169916;Presinol;Presolisin; |
CAS: | 555-30-6 |
EINECS: | 209-089-2 |
Molecular Formula: | C10H13NO4 |
Molecular Weight: | 211.22 |
InChI: | InChI=1/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1 |
Molecular Structure: |
|
Properties |
Density: | 1.403g/cm3 |
Stability: | Stable under normal temperatures and pressures. |
Solubility: | 10 g/L |
Appearance: | Colorless or almost colorless crystals or white to yellowish-white fine powder. Almost tasteless. In the sesquihydrate form. |
Specification: |
Side effects:
?Methyldopa (CAS NO.555-30-6) is capable of inducing a number of adverse side effects, which range from mild to severe. Nevertheless, they are generally mild when the dose is less than 1 gram per day.Side effects may include:
Psychological
Depression and/or even suicidal ideation, as well as nightmares
Apathy and/or anhedonia, as well as dysphoria
Anxiety, especially of the social anxiety variant
Decreased alertness, awareness, and wakefulness
Impaired attention, focus, and concentration
Physiological
Dizziness, lightheadedness, or vertigo
Miosis or pupil constriction
Xerostomia or dry mouth
Gastrointestinal disturbances such as diarrhea and/or constipation
Headache or migraine
|
Biological Activity: | L-aromatic amino acid decarboxylase inhibitor. Antihypertensive. |
Storage Temperature: | Keep container closed when not in use. Store in a cool, dry, well-ventilated area away from incompatible substances. |
Color: | Minute, anhyd crystals from methanol WHITE TO YELLOWISH WHITE, FINE POWDER, WHICH MAY CONTAIN FRIABLE LUMPS |
Usage: | Antihypertensive agent. |
Safety Data |
|
|